Scientific Updates

      Scientific Update December 2021 Issue 14

      PMI

      Published on
      Dec 15, 2021
      Link to more information
      Topic
      Summary

      PMI releases its latest Scientific Update 14, a regular publication on its research efforts to further tobacco harm reduction and to develop and assess a range of potentially reduced-risk alternatives to cigarettes.

      The 14th issue of the Scientific Update features an editorial by Dr. Angela van der Plas, Manager Real-World Evidence & Epidemiology. There, she describes how a scientific approach to research can be used by anyone, not just scientists.

      This issue on real-world evidence discusses the vital role science-based decision-making plays in our sustainability program and describes the physics that make our heated tobacco products work. Another highlight from this issue details our real-world evidence in the context of our product assessment program, including what is meant by the term real-world evidence, where the data comes from, and some examples of the evidence that has been collected on our leading smoke-free product.

      Flip through the pages of our latest Scientific Update to learn more.

      Related Publications

      Use of capillary aerosol generator in continuous production of controlled aerosol for non-clinical studies

      Aerosol Physics Pre-clinical Toxicology

      Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters

      Pre-clinical Toxicology

      Quantification and mapping of alkylation in the human genome reveal single nucleotide resolution precursors of mutational signatures

      Pre-clinical Toxicology

      Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels

      Clinical

      An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power

      Pre-clinical Toxicology

      Tobacco heating system has less impact on bone metabolism than cigarette smoke

      Pre-clinical Toxicology

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.